Device Trial Radar · NCT07629232
Measuring Corneal Parameters
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Jun 1, 2026
Primary completion
Sep 30, 2026
Study completion Sep 30, 2026
Sponsor
- Lead sponsor
- Icare Finland OyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 5, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The aim of this clinical investigation is to assess the feasibility of the investigational device for measuring corneal parameters of the human eye.
Conditions
- Corneal Parameters
Interventions
Investigational deviceDevice
Measurement of corneal parameters
Comparator deviceDevice
Measurement of corneal parameters
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary objective of this study is to collect a comprehensive dataset of central corneal thickness (CCT) values to assess the performance of investigational device.Time frame: Through study completion, an average of 2 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Universitäts-Augenklinik Bonn
Bonn, North Rhine-Westphalia, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.